Genetic Testing Company Assessment
Clinical Diagnostics
400+
4
Target Identification
Objective
A group asked DeciBio to identify and evaluate clinical genetic testing labs for potential acquisition
Our Approach
Primary Research
- Conducted 4 supplementary KOL interviews to assist in company deep dives
Secondary Research
- Collated a list of 400+ U.S. genetic testing laboratories from public sources (e.g., databases, press releases, news), narrowing the list down to 10 identified candidates based on viability
- Conducted deep dives into the 4 most attractive potential targets
Outcome
DeciBio narrowed a pool of 400+ U.S. laboratories down to 4 high priority potential targets, then profiled each, including information such as:
- Annual test volumes
- Valuation
- Portfolio breadth
- Test performance
- Analysis of opportunities and drawbacks
Related Client Results
MRD Monitoring Market Assessment and Strategy
Biomarker and Diagnostics Strategy
Go-to-Market Strategy
Market Landscaping and Sizing
Low-Throughput Molecular Diagnostic Testing Landscape Assessment
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
PE-Backed Life Sciences Tools Platform Development
Voice-of-Customer Research
Customer Segmentation
Pricing Strategy
Due Diligence
Competitive Analysis
